BioAtla, Inc. — Director's Dealing 2021

Oct 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioAtla, Inc. (BCAB)
CIK: 0001826892
Period of Report: 2021-10-01

Reporting Person: Smith Scott Andrew (Director, President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-01	Common Stock	S	2994	$30.1775	Disposed	351725	Direct

Footnotes

F1: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs.

F2: The range of prices for the shares of Common Stock is from $30.10 to $30.41. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.